Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-10-03
2006-10-03
Switzer, Juliet C. (Department: 1634)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07115726
ABSTRACT:
The present invention includes the use of any of the polymorphisms, SNP haplotype blocks or SNP haplotype patterns. In one embodiment, susceptibility to a phenotype resulting from an allele or marker in linkage disequilibrium with such polymorphic forms is evaluated. Novel therapeutic and diagnostic compounds and methods are also disclosed.
REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5412087 (1995-05-01), McGall et al.
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5459325 (1995-10-01), Hueton et al.
patent: 5474796 (1995-12-01), Brennan
patent: 5578832 (1996-11-01), Trulson et al.
patent: 5744305 (1998-04-01), Fodor et al.
patent: 5800992 (1998-09-01), Fodor et al.
patent: 5837832 (1998-11-01), Chee et al.
patent: 5953727 (1999-09-01), Maslyn et al.
patent: 5981956 (1999-11-01), Stern
patent: 6040138 (2000-03-01), Lockhart et al.
patent: 6040193 (2000-03-01), Winkler et al.
patent: 6262838 (2001-07-01), Montagu
patent: 6274332 (2001-08-01), Keating et al.
patent: 6300063 (2001-10-01), Lipshutz et al.
patent: 6323026 (2001-11-01), Keating et al.
patent: 2004/0086886 (2004-05-01), Goldstein
patent: 0717113 (1996-06-01), None
patent: 0950720 (1999-10-01), None
patent: 9511995 (1995-05-01), None
patent: 9523225 (1995-08-01), None
patent: 9710365 (1997-03-01), None
patent: 9727317 (1997-07-01), None
patent: 9856954 (1998-12-01), None
patent: WO 99/52942 (1999-10-01), None
patent: 0180156 (2001-10-01), None
Pennisi, Science, 281 (5384):1787-1789.
Hacker et al. Gut, 1997, vol. 40, pp. 623-627.
dbSNP record ss4013642, entry date Sep. 26, 2001.
GenBank Record having Accession A24697 (GI: 833430), dated Jan. 24, 1995.
GenBank Record having Accession Z30080 (GI: 454996), dated Feb. 15, 1994.
Altshuler, D., Daly, M., Kruglyak, L. “Guilt by Association”Nature Genetics26, 135-137 (2000).
Priori, S.G., Barhanin, J., Hauer, R.N.W., Haverkamp, W., Jongsma, H.J., Kleber, A.G., McKenna, W.J., Roden, D.M., Rudy, Y., Schwartz, K., Schwartz, P.J., Towbln, J.A., Wilde, A.M. “Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II”Circulation99:518-28 (1999).
Kruglyak, L., Nickerson, D.A. “Variation is the spice of life”Nature Genetics27, 234-236 (2001).
Daly, M.J., Rioux, J.D., Schaffner, S.F., Hudson, T.J., Lander, E.S. “High-resolution haplotype structure in the human genome” Nature Genetics 29, 229-232, (2001).
Agarwal, P. et al. “Comparison study for identifying promoter allelic polymorphism in interleukin 10 and tumor necrosis factor alpha genes” Diagn Mol Pathol 9, 158-64(2000).
Moss, A.J., Zareba, W., Hall, W.J., Schwartz, P.J., Crampton, R.S., Benhorin, J., Vincent, M., Locati, E.H., Priori, S.G., Napolitano, C., Medina, A., Zhang, L., Robinson, J.L., Timothy, K., Towbin, J.A., Andrews, M.L. “Effectiveness and Limitations ofbeta-Blocker Therapy in Congenital Long-QT Syndrome”Circulation101:616-23 (2000).
Fullerton, S.M. et al. “Apolipoprotein E Variation at the Sequence Haplotype Level: Implications for the Origin and Maintenance of a Major Human Polymorphism”The American Society of Human Genetics67, 881-900 (2000).
Marth, G. et al. “Single-nucleotide polymorphisms in the public domain: how useful are they?”Nature Genetics27, 371-372 (2001).
Yang, Z. et al. “Sampling SNPs”Nature Genetics26, 13-14 (2000).
Atlshuler, D., et al. “The common PPAR Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes”Nature Genetics26, 76-80 (2000).
Douglas, J.A. et al. “Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies”Nature Genetics28, 361-364 (2001).
Roses, A.D. “Pharmacogenetics”Human Molecular Genetics10, 2261-2267 (2001).
Splawski, I., et al. “Spectrum of Mutations in Long-QT Syndrome GenesKVLQT1, HERG, SCN5A, KCNE1, andKCNE2” Circulation102:1178-85 (2000).
Evans, W.E., Relling, M.V. “Pharacogenetics: Translating Functional Genomics into Rational Therapeutics”Science Magazine286, 487-491 (1999).
Lizardi, P.M. et al. “Mutation detection and single-molecule counting using isothermal rolling-circle amplification”Nature Genetics19, 225-232 (1998).
Chee, M. et al. “Accessing Genetic Information with High-Density DNA Arrays”Science Magazine274, 610-614 (1996).
Sambrook, J., et al.,Molecular Cloning A Laboratory Manual, Third Edition, Cold Spring Harbor Laboratory Press (2001), table of contents & p. 11.98-11.105 only.
Atlshuler, D., et al. “An SNP map of the human genome generated by reduced representation shotgun sequencing”Nature407, 513-516 (2000).
Reich, D.E. et al. “Linkage disequilibrium in the human genome”Nature411, 199-204 (2001).
Stephens, J.C. et al. “Haplotype Variation and Linkage Disequilibrium in 313 Human Genes”Science Magazine293, 489-493 (2001).
Doll, J.J. “The Patenting of DNA”Science Magazine280, 689-690 (1998).
Pennacchio, L.A., Rubin, E.M. “Genomic Strategies to Identify Mammalian Regulatory Sequences”Nature2, 100-109 (2001).
Lockhart, D.J., Winzeler, E.A., “Genomics, gene expression and DNA arrays”Nature405, 827-836 (2000).
Lander, E.S. “The New Genomics: Global Views of Biology”Science Magazine274, 536-539 (1996).
McCarthy, J.J., Hilfiker, R. “The use of single-nucleotide polymorphism maps in pharmacogenomics”Nature Biotechnology18, 505-508 (2000).
Rothberg, B.E., “Mapping a role for SNPs in drug development”Nature Biotechnology19, 209-211 (2001).
Riley, J.H. et al. “The use of single nucleotide polymorphisms in the isolation of common disease genes”Pharmacogenomics. 1(1):39-47, (2000).
Cardon, L.R., Bell, J.I. “Association Study Designs for Complex Diseases”Nature2, 91-99 (2001).
Wang, D.G., “Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome”Science Magazine280, 1077-1082 (1998).
Cargill, M., Daley, G.Q., “Mining for SNPs: putting the common variants-common disease hypothesis to the test”Pharamacogenomics. 1(1):27-37, (2000).
Karet, G. et al. “Unraveling Human Diversity”Drug Discovery&Development MagazineNov./Dec. S5-S14 (2000).
Lai, E. “Application of SNP Technologies in Medicine: Lessons Learned and Future Challenges”Genome Research1, 927-929 (2001).
Jorde, L.B., “Linkage Disequilibrium and the Search for Complex Disease Genes”Genome Research10, 1435-1444 (2000).
Cormen, T.H., et al., “Introduction to Algorithms” Fourteenth printing, 1994, table of contents only.
Fu, Y.X., Li, W.H. “Statistical Tests of Neutrality of Mutations”Genetics133: 693-709 (1993).
Risch, N., Merikangas, K. “The Future of Genetic Studies of Complex Human Diseases”Science Magazine273, 1516-1517 (1996).
Kota, R. “Application of denaturing high-performance liquid chromatography for mapping of single nucleotide polymorphisms in barley (Hordeum vulgare L.)”Genome44: 523-528, (2001).
Shapero, M.H. “SNP Genotyping by Multiplexed Solid-Phase Amplification and Flourescent Minisequencing”Genome Research11, 1926-1934 (2001).
Shoemaker,D.D. “Experimental annotation of the human genome using microarray technology”Nature409, 922-927 (2001).
Cutler, D.J. et al. “High-Throughput Variation Detection and Genotyping Using Microarrays”Genome Research11, 1913-1925 (2001).
Waterston, R.H. et al. “A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms”Nature409, 928-933 (2001).
Judson R, Stephens JC. “The predictive power of haplotypes in clinical response”Pharmacogenomics. 1(1):15-26, (2000).
Patil, N., et al. “Blocks of Limited Haplotype Diversity Revealed by High-Resolution Sc
Arnold Deana A.
Cox David R.
Arnold Deana A.
Perlegen Sciences, Inc.
Shaver, Esq. Gulshan U.
Switzer Juliet C.
LandOfFree
Haplotype structures of chromosome 21 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Haplotype structures of chromosome 21, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Haplotype structures of chromosome 21 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3643408